A Rapid Interference between Glucocorticoids and cAMP-Activated Signalling in Hypothalamic Neurones Prevents Binding of Phosphorylated cAMP Response Element Binding Protein and Glucocorticoid Receptor at the CRE-Like and Composite GRE Sites of Thyrotrophin-Releasing Hormone Gene Promoter

• Published in: Journal of neuroendocrinology Vol. 22; no. 4; pp. 282 - 293
• Main Authors: Díaz-Gallardo, M. Y., Cote-Vélez, A., Charli, J. L., Joseph-Bravo, P.
• Format: Journal Article
• Language: English
• Published: Oxford, UK Blackwell Publishing Ltd 01-04-2010; Blackwell
• Subjects: Animals; Biological and medical sciences; Cells, Cultured; composite-GRE; corticosterone-BSA; CREB; Cyclic AMP - antagonists & inhibitors; Cyclic AMP - pharmacology; Cyclic AMP Response Element-Binding Protein - metabolism; Drug Antagonism; Female; Fundamental and applied biological sciences. Psychology; Gene Expression Regulation - drug effects; Glucocorticoids - antagonists & inhibitors; Glucocorticoids - pharmacology; hypothalamus; Hypothalamus - drug effects; Hypothalamus - metabolism; Neurons - drug effects; Neurons - metabolism; Phosphorylation; Pregnancy; pro-TRH; Promoter Regions, Genetic - drug effects; Protein Binding - drug effects; Rats; Rats, Wistar; Receptors, Glucocorticoid - metabolism; Response Elements - drug effects; Signal Transduction - drug effects; Thyrotropin-Releasing Hormone - genetics; Time Factors; Vertebrates: endocrinology; Phosphorylation; Steroid hormone; Corticosterone; Transcription promoter; Central nervous system; corticosterone-BSA; Cyclic AMP; Thyroid stimulating hormone; Hypothalamus; Glucocorticoid; Encephalon; Hypothalamic hormone; Thyrotropin releasing hormone; CREB; Adenohypophyseal hormone; Adrenal hormone; Glucocorticoid receptor; composite-GRE; Hormone releasing factor; Transcription factor CREB; Thyrotrophin; pro-TRH
• DOI: 10.1111/j.1365-2826.2010.01966.x
• EISSN: 1365-2826
• ISSN: 0953-8194

Glucocorticoids or cAMP increase, within minutes, thyrotrophin‐releasing hormone (TRH) transcription in hypothalamic primary cultures, although this effect is prevented if cells are simultaneously incubated with both drugs. Rat TRH promoter contains a CRE site at −101/−94 bp and a composite GRE element (cGRE) at −218/−197 bp. Nuclear extracts of hypothalamic cells incubated with 8Br‐cAMP or dexamethasone, and not their combination, bind to oligonucleotides containing the CRE or cGRE sequences. Adjacent to CRE are Sp/Krüppel response elements, and flanking the GRE half site, two AP1 binding sites. The present study aimed to identify the hypothalamic transcription factors that bind to these sites. We verified that the effects of glucocorticoid were not mimicked by corticosterone‐bovine serum albumin. Footprinting and chromatin immunoprecipitation (ChIP) assays were used to examine the interaction of cAMP‐ and glucocorticoid‐mediated regulation of TRH transcription at the CRE and cGRE regions of the TRH promoter. Nuclear extracts from hypothalamic cells incubated for 1 h with cAMP or glucocorticoids protected CRE. The GRE half site was recognised by nuclear proteins from cells stimulated with glucocorticoids and, for the adjacent AP‐1 sites, by nuclear proteins from cells stimulated with cAMP or phorbol esters. Protection of CRE or cGRE was lost if cells were coincubated with dexamethasone and 8Br‐cAMP. ChIP assays revealed phospho‐CREB, c‐Jun, Sp1, c‐Fos and GR antibodies bound the TRH promoter of cells treated with cAMP or glucocorticoids; anti:RNA‐polymerase II immunoprecipitated TRH promoter in a similar proportion as anti:pCREB or anti:GR. Recruitment of pCREB, SP1 or GR was lost when cells were exposed simultaneously to 8Br‐cAMP and glucocorticoids. The data show that while pCREB and Sp1 bind to CRE‐2, or GR to cGRE of the TRH promoter, the mutual antagonism between cAMP and glucocorticoid signalling, which prevent their binding to TRH promoter, could serve as a mechanism by which glucocorticoids rapidly suppress cAMP and noradrenaline‐stimulated TRH transcription.